Day E D, Hashim G A, Varitek V A, Paterson P Y
Neurochem Res. 1981 May;6(5):577-93. doi: 10.1007/BF00964395.
Equilibrium and nonequilibrium competitive inhibition analyses of a number of antisera to peptide S81 and S82 sequences were carried out through the use of inhibition radioimmunoassays with [125I]S81, [125I]S82, and [125I]S79 and a panel containing 18 related peptides and five myelin basic protein preparations. Two principal determinants were identified, one of them sequential, the other nonsequential. The sequential determinant involved a peptide at or near the C-terminal end of S82 that could be blocked by an interchange of asparagine for glycine at the C terminus. The nonsequential determinant was dominant for a number of rabbit and rat antisera, both anti-S82 and anti-S81, and was shared not only by S81 and S82 but also by S8 and S80, i.e., the family of residues of bovine MBP sequence 69-83. Neither determinant was expressed in any of the myelin basic protein preparations, and the nonsequential determinant was not expressed in peptide sequences smaller than S8.
通过使用针对[125I]S81、[125I]S82和[125I]S79的抑制性放射免疫测定法以及一个包含18种相关肽和5种髓鞘碱性蛋白制剂的组合,对多种针对肽S81和S82序列的抗血清进行了平衡和非平衡竞争性抑制分析。确定了两个主要决定簇,其中一个是连续的,另一个是非连续的。连续决定簇涉及S82 C末端或其附近的一个肽,该肽可通过在C末端将天冬酰胺替换为甘氨酸而被阻断。非连续决定簇对许多兔和大鼠抗血清(抗S82和抗S81)具有主导作用,并且不仅S81和S82共享,S8和S80也共享,即牛髓鞘碱性蛋白序列69 - 83的残基家族。在任何髓鞘碱性蛋白制剂中均未表达这两个决定簇,并且在小于S8的肽序列中未表达非连续决定簇。